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BRIEF ARTICLE
Abstract
Background and objective: To evaluate access to sterile sy-
ringes and its association with injection risk behaviour in Ma-
drid and Barcelona.
Materials and methods: Cross-sectional community study by
computer-assisted personal interview in 465 young heroin in-
jectors between 2001 and 2003.
Results: Some 4.2% had not obtained any free sterile sy-
ringes in the previous 12 months. In Madrid 32.1% had ob-
tained all their sterile syringes free of charge (ASSF), versus
44.6% in Barcelona (p < 0.01). Not sharing (not using syrin-
ges used by someone else and not front/backloading) was as-
sociated with obtaining ASSF (OR = 1.69) and with sporadic
injection (OR = 1.83). Not reusing one’s own syringes was as-
sociated with the same two variables (OR = 4.02 and OR =
2.50, respectively).
Conclusions: Access to sterile syringes is very high in Ma-
drid and Barcelona, although the two cities have different ap-
proaches. The acquisition of all syringes free of charge should
be facilitated, especially among frequent injectors.
Key words: Drug injection. Syringe exchange programmes.
Risk behaviour. HIV.
Resumen
Objetivo: Evaluar el acceso a jeringas estériles y su asociación
con prácticas de inyección de riesgo en Madrid y Barcelona.
Material y método: Estudio transversal en la comunidad de
465 jóvenes que se inyectan heroína, realizado entre 2001 y
2003, mediante entrevista asistida por ordenador.
Resultados: Un 4,2% no obtuvo jeringas estériles gratuitas
en los últimos 12 meses. En Madrid, el 32,1% obtuvo todas
las jeringas estériles gratis (TJEG), frente al 44,6% de Bar-
celona (p < 0,01). No compartir (no utilizar jeringas ajenas usa-
das o droga diluida en las usadas por otros) se asoció con
obtener TJEG (odds ratio [OR] = 1,69) e inyectarse esporá-
dicamente (OR = 1,83). No reutilizar las jeringas propias se
asoció con las mismas variables (OR = 4,02 y OR = 2,50, res-
pectivamente).
Conclusiones: En Madrid y Barcelona el acceso a jeringas
estériles es muy elevado, aunque con modelos diferentes. Debe
facilitarse la obtención de todas las jeringas estériles gratis,
especialmente entre los jóvenes que se inyectan con mayor
frecuencia. 
Palabras clave: Inyección de drogas. Programas de inter-
cambio de jeringas. Conductas de riesgo. VIH.
Access to sterile syringes among young drug injectors in Madrid
and Barcelona and its association with risk behaviour
María J. Bravoa / Luis Royuelab / Gregorio Barrioc / M.a Teresa Brugald / Antònia Domingoe / Luis de la Fuentef
and Itínere Project Group*
aCIBER Epidemiología y Salud Pública (CIBERESP); bEuropean Monitoring Centre for Drugs and Drug Addiction; cDepartamento 
de Medicina Preventiva, Salud Pública e Historia de la Ciencia, Universidad Complutense de Madrid, Madrid, España; 
dAgència de Salut Pública de Barcelona, Barcelona, España; dInstitut Municipal d’Investigació Médica (IMIM), Barcelona, España;
fCentro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, España. 
(Acceso a jeringas estériles entre los jóvenes de Madrid
y Barcelona que se inyectan drogas y su asociación 
con las prácticas de riesgo)
*Itínere Project Group: Rosario Ballesta, Francisco González,
Francisco Bru, Yolanda Castellano, David Fernández, Daniel
Lacasa, Eusebio Mejías, Montserrat Neira, José Pulido, Sofía
Ruiz, Fernando Sánchez, Teresa C Silva y Fernando Vallejo.
Correspondence: Luis de la Fuente.
Centro Nacional de Epidemiología. 
Instituto de Salud Carlos III. Madrid.
Sinesio Delgado 6. 28029 Madrid. Spain.
E-mail: mbravop@isciii.es
Received: 6 October 2006.
Accepted: 12 June 2007.
Introduction
over the last 15 years, a growing number of ini-tiatives have facilitated the provision of sterilesyringes to drug injectors in Spain, primarily sy-ringe exchange programmes (SEPs) and sub-
sidised sales in pharmacies. The SEPs have branched
out to new locations1, and some injectors obtain their
supplies through these programmes and subsequently
sell them2 (satellite distributors – SDs)3. However, the
development of the SEPs has not been geographically
homogeneous: in 2003 there were 254 SEPs with 1,560
exchange points (EPs) (each location or site where sy-
ringe exchange takes place), 799 of which (51.2%) were
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Table 1. Proportion of young drug injectors who obtain all their sterile syringes free of charge, according to variables related 
with sociodemographics, injection, sexual behaviour and serological status (HIV, HCV). Itínere Project, 2001-03
n Percentage p
City
Madrid 60/185 32.1 < 0.01
Barcelona 115/258 44.6
Current age 
 25 79/186 42.5 NS
> 25 96/259 37.1
Sex
Male 126/330 38.2 NS
Female 49/115 42.6
Nationality
Foreign 139/374 37.2 < 0.05
Spanish 36/71 50.7
Type of residence
Houses, flats, shanties, occupied houses 123/342 36.0 < 0.01
Streets, parks, no fixed abode and others 52/103 50.5
Marginal or illegal activity to obtain money
Yes 111/257 43.2 0.051
No 64/188 34.0
Years of drug injection
> 5 91/234 38.9 NS
5 82/206 39.8
Educational level
Primary or lower 68/168 40.5 NS
Higher than primary 106/276 38.4
Employment status NS
Working 52/136 38.2
Not working 123/309 39.8
Frequency of injection of any drug
Habitual (weekly or more) 122/339 36.0 < 0.05
Sporadic (less than once a week) 50/100 50.0
Most frequent location for drug injection
Private place (houses) 27/69 39.1 NS
Squares, abandoned houses, cars, other 41/92 44.6
Place where drugs are sold and consumed 107/284 37.7
Injected with syringes used by others (a)
Yes 33/111 29.7 < 0.05
No 139/322 43.2
Used own or others’ syringes to backload (b)
Yes 33/111 29.7 < 0.05
No 142/334 42.5
Introduced the syringe into a recipient used by others 
Yes 62/160 38.8 NS
No 113/284 39.8
Cleaned skin with used cloths 
Yes 1/16 6.3 < 0.01
No 174/429 40.6
Rinsed needles or syringes in liquid used by others
Yes 18/53 34.4 NS
No 157/391 40.2
Gave used syringes to others
Yes 18/78 23.1 < 0.01
No 156/366 42.6
Reused own syringes
Yes 81//289 28.1 < 0.001
No 94/155 60.6
(Continues)
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in Catalonia and 66 (4.2%) in the Community of Madrid1.
Moreover, 664 pharmacies in Catalonia had an SEP, ver-
sus only 12 pharmacies in the Community of Madrid1.
Free syringes could be obtained only in the SEPs and
there were no subsidised sales.
In other countries, SDs have been shown to impro-
ve access to sterile syringes in certain places or at cer-
tain times4,5 although these informal resources are as-
sociated with a greater risk of HIV infection than the use
of more structured programmes4. The extent of SEP co-
verage is critical to assuring their effectiveness6.
The aim of this work is to describe the differences
in access to sterile syringes among injectors in Madrid
and Barcelona and to study sterile syringe access as
a predictor of safer injection practices that may prevent
the transmission of bloodborne infections.
Materials and methods
The methodology used in the ITÍNERE cohort has pre-
viously been described in detail7. Independently of the
social services, 991 young adults (18-30 years old) were
recruited in the cities of Madrid, Barcelona and Seville bet-
ween April 2001 and December 2003. All participants had
used heroin on at least 12 days in the previous 12 months
and on at least 1 day in the previous 3 months. The pre-
sent analysis was restricted to the 465 participants from
Madrid and Barcelona who had injected the drug in the
previous 12 months and who answered three pre-coded
questions: 1) Of all the sterile syringes you have used in
the last 12 months, how many did you obtain free of char-
ge? 2) From what kind of organization or service did 
you obtain the most free syringes in the last 12 months?
3) Where did you buy most of the syringes you purcha-
sed during this same time period? The 2.5% of injection
drug users who did not respond were excluded. Their pro-
file did not differ significantly from the rest of the popula-
tion in terms of the main variables. The questionnaire7 was
computer-assisted. Dried blood spot samples were also
analysed (HIV, HCV).
The statistical significance of the differences was eva-
luated with the Chi square test for qualitative variables and
by analysis of variance with subsequent comparisons with
Scheffé’s test for quantitative variables. Two dependent
variables were explored separately in the logistic regres-
sion: «sharing» – injecting with used syringes or front/bac-
kloading (i.e., employing a used syringe to prepare the
drug solution, which is then divided into one or more sy-
ringes for injection) and «reusing one’s own syringes» –
because these practices involve very different risks of trans-
mitting infections and to avoid problems of co-linearity. 
Results
Most respondents were men (73.4%), born in Spain
(84.9%), and without regular employment (69.2%); their
mean age was 25.8 years (95% CI 25.5-26.1) and mean
duration of injecting drug use was 6.5 years (95% CI
6.0-6.91). Some 86.5% had injected in the last 30 days.
Injection in private places, such as flats or houses, was
more frequent in Barcelona (19.3%) than in Madrid
(11.4%), where it more often took place in open places
(sites of drug sales or consumption, public squares,
abandoned houses or similar places) (p < 0.05).
Only 4.2% (20) had not obtained any free sterile sy-
ringes in the last 12 months, 1.9% in Barcelona and 7.4%
in Madrid (p < 0.01). These injectors differed from the
rest of the sample in that they were more frequently
Table 1. Proportion of young drug injectors who obtain all their sterile syringes free of charge, according to variables related 
with socio-demographics, injection, sexual behaviour and serological status (HIV, HCV). Itínere Project, 2001-03 (continue)
n Porcentage p
Injected with syringes used by others or front/backloaded (a or b) 
Yes 56/176 31.8 < 0.01
No 119/269 44.2
Exchanged sex for money, drugs or other merchandise
Yes 37/85 43.1 NS
No 138/359 38.9
HIV positive
Yes 44/114 38.6 NS
No 130/328 39.6
HCV positive
Yes 124/324 38.3 NS
No 49/117 41.9
HIV: Human immunodeficiency virus; HCV: Hepatitis C virus; NS: no statistical significance (p > 0.05).
All practices refers to the last 12 months.
women (45.0% vs. 25.8%; p=0.058) and sporadic
users (61.1% vs. 22.8%; p < 0.001), and they less often
injected in places where drugs are sold or consumed
(10.0% vs. 63.8%; p < 0.001).
The way syringes were acquired – either all steri-
le syringes free of charge (ASSF) through SEPs or free
plus purchased sterile syringes – was significantly as-
sociated with the city of residence. The proportion of
drug users who obtained ASSF was smaller in Madrid
than in Barcelona (table 1). In Barcelona, 62.8% ob-
tained most of their free syringes from SEPs located
in buses or vans, 20.5% from SEPs in pharmacies,
7.8% from SEPs at fixed locations, 5.7% through street-
based social workers or educators and 3.1% in other
ways. In Madrid, the respective percentages were
82.5%, 0.5%, 8.7%, 2.7% and 5.5% (p < 0.001). Of
those who had purchased syringes in the 12 months
before the interview (286), 51.7% had bought them pri-
marily in pharmacies and 48% in the street (67% and
32.4%, respectively, in Barcelona, vs. 34.8% and 65.2%
in Madrid, p < 0.001). Obtaining ASSF was also sig-
nificantly and positively associated with being Spanish,
not having a fixed abode, injecting drugs sporadically
and not exhibiting most of the injection risk behaviour
investigated. 
After adjusting for city, sociodemographic variables
(sex, age, country of birth, educational level, employment
status and type of residence), frequency of injection, years
of injection, HIV and HCV status, prostitution and way of
obtaining sterile syringes, «not sharing» (not injecting with
used syringes and not front/backloading in syringes used
by others) was associated with obtaining ASSF (OR =
1.69; 95% CI 1.11-2.56) and sporadic injection (OR = 1.83;
95% CI 1.11-3.03). Not reusing one’s own syringes was
associated with the same variables (OR = 4.02; 95% CI
2.59-6.24; and OR = 2.50; 1.52-4.12, respectively) (table
2). Among those who purchased syringes, a significant
association was seen between not reusing and buying
most syringes in the street (OR = 1.85 95% CI 1.02-3.34).
Not sharing was not associated with the way syringes were
purchased. 
Discussion
This is the first study of access to sterile syringes
in a community sample of drug injectors in Spain. Free
sterile syringes were found to be widely accessible in
Madrid and Barcelona, which is consistent with the con-
siderable increase in SEPs over the last 15 years1,2. Ho-
wever, there are important differences between the two
cities: a smaller proportion obtained ASSF in SEPs in
Madrid, where those who purchased syringes most often
bought them in the street. Both findings are consistent
with the much larger number of EPs in Barcelona8 (141)
than in Madrid (27-31; personal communication, Marta
Franco) in 2003, and with the small number of phar-
macies authorised for syringe exchange in the latter city1.
It is possible that the number of syringes provided by
the SEPs per year to each injector was not less in Ma-
drid, but that a substantial proportion of syringes reach
users through SDs and thus are not free of charge. It
may also be that the number of free sterile syringes put
into circulation in Madrid was too low to meet the de-
mand. Although it is not easy to estimate coverage when
the number of users is unknown, NGOs and local go-
vernments should make an effort in this regard. Fur-
thermore, a certain balance should be maintained bet-
ween structured programmes and informal resources
that do not focus on transmitting preventive messages,
do not collect used syringes, and do not fully guaran-
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Table 2. Factors associated with not sharing syringesa, or not reusing one’s own syringes among young heroin injectors. 
Itínere Project, 2001-03. Multivariate logistic regression analysis
Not sharing Not reusing
OR 95% IC OR 95% IC
Way sterile syringes were obtained
Free in SEP and purchased from pharmacy or in the street 1.00 1.00
All free in SEP 1.69 1.11-2.56 4.02 2.59-6.24
Frequency of injection
Habitual (weekly or more) 1.00 1.00
Sporadic (less than once a week) 1.83 1.11-3.03 2.50 1.52-4.12
Marginal or illegal activities to earn money
Yes 1.00 1.00
No 1.59 1.04-2.43 1.53 0.97-2.43
aNot sharing syringes = not injecting with syringes used by others and not front/backloading. Reference period: last 12 months. Both models were adjusted by city, 
sociodemographic variables, years of injection, HIV and HCV serological status and prostitution. N.º of cases retained in each model = 439. SEP = Syringe exchange 
programs. CI: confidence interval.
tee the sterility of injection material4,9. It may be ne-
cessary to seek mechanisms to involve such a wides-
pread resource as SDs in a structured way, as health
agents.
In Madrid injection is more frequent in public or open
places, and syringes are more often obtained in mobi-
le SEPs. This seems consistent with the existence of
a single vehicle-based programme in Barcelona, which
in practice is used as a fixed site, and of public places
where drugs are sold and consumed in many parts of
Madrid. The characteristics of the illegal drug market
and the needs of the injector should guide the types of
SEPs to be developed, without forgetting that the cha-
racteristics or location of the programme may in some
measure affect the choice of injection site.
It is logical that a smaller proportion of frequent in-
jectors obtain ASSF; however, this could seriously limit
the effectiveness of SEPs10, since those who inject more
often have more opportunities to share injection mate-
rial and to reuse their own. In fact, the regression analy-
sis showed that those who inject fewer times, as well
as those who obtain ASSF, have less risk behaviour (not
sharing or not reusing). Frequent injectors need to have
greater access to ASSF, particularly considering the high
prevalence of different ways of sharing injection mate-
rial3,11 and the high incidence of HIV or HCV in injec-
tors in both cities12. Moreover, among those who buy
syringes, access to SDs has a protective effect with re-
gard to reuse of one’s own syringes. However, this re-
source seems to have a limited capacity to prevent sha-
ring of injection material, which would support a greater
effect of SEPs as compared to informal resources for
HIV prevention4,9.
This study has limitations stemming from its cross-
sectional design in a difficult-to-access population lac-
king a clear sampling framework, thus it is difficult to
know the extent to which the sample is representative.
To reduce socially desired responses, the interviews were
not conducted either in treatment centres for drug de-
pendence or in SEPs.
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